로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > MMP-1

MMP-1

요약

Name:Matrix metalloproteinase-1
Target Synonym:Matrix Metallopeptidase 1 (Interstitial Collagenase),Matrix Metallopeptidase 1,Matrix Metalloproteinase-1,EC:3.4.24.7,EC 3.4.24.7,CLG,Fibroblast Collagenase,Matrix Metalloproteinase 1 (Interstitial Collagenase),CLGN,MMP1,Matrix Metalloproteinase 1,MMP-1,EC 3.4.24,Interstitial Collagenase,Matrix Metalloprotease 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
MM1-H52H3 Human Human MMP-1 Protein, His Tag (active enzyme, MALS verified)
MM1-H52H3-structure
MM1-H52H3-sds

일부의 생물활성 데이터

MM1-H52H3-MALS-HPLC
MMP-1 MALS images

The purity of Human MMP-1 Protein, His Tag (Cat. No. MM1-H52H3) is more than 85% and the molecular weight of this protein is around 60-80 kDa verified by SEC-MALS.

Synonym Name

MMP1,CLG,CLGN

Background

Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. Thrombospondins, intervertebral disc proteins, regulate the effective levels of matrix metalloproteinases (MMPs) 2 and 9, which are key effectors of ECM remodeling. Matrix metalloproteinase-1 (MMP-1) is also known as interstitial collagenase and fibroblast collagenase. MMP

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
FCX-013 FCX-013; HDF-LV-RTS-MMP1 Details
BT-1718 BDC-17; BT-1718 Phase 2 Clinical Bicycle Therapeutics Solid tumours; Esophageal Neoplasms; Neoplasms; Sarcoma; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop